Ignite Creation Date:
2024-05-05 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00086580
Status:
COMPLETED
Last Update Posted:
2014-03-13
First Post:
2004-07-06
Brief Title:
Fludarabine Fludara Plus Alemtuzumab CAMPATH MabCampath vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia B-CLL Patients
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Organization Data
Organization:
Sanofi
Class:
INDUSTRY
Study ID:
CAM314
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Genzyme a Sanofi Company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None